Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Asa Rembratt"'
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 42:274-277
The purpose of this trial was to investigate whether a renal concentrating capacity test with desmopressin could be performed with oral tablets instead of the previously used nasal spray.A total of 154 children aged 3-18 years, who were candidates fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2942828f4c5876be422fd1b1efaa87
https://doi.org/10.1080/00365590701685736
https://doi.org/10.1080/00365590701685736
Autor:
Laura Rabinovich-Guilatt, Asa Rembratt, Atef Halabi, Ofer Spiegelstein, Armin Schultz, Karl Ernst Siegler
Publikováno v:
British Journal of Clinical Pharmacology
Aim Pridopidine, a new oral drug for treatment of patients with motor symptoms associated with Huntington's Disease (HD) is currently under development. In steady-state conditions, pridopidine elimination is mediated primarily through renal excretion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9041d19f08a26056f8e632b019857613
https://pubmed.ncbi.nlm.nih.gov/26407011
https://pubmed.ncbi.nlm.nih.gov/26407011
Publikováno v:
Pediatric nephrology (Berlin, Germany). 16(5)
A crossover trial was undertaken to evaluate the bedtime administration of desmopressin (Minirin) as a renal concentrating capacity test (RCCT). Medication was given intranasally as a single 20-microgram dose to 58 children ranging from 3 to 15 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0fff21307260f1a6c9c7c863c72ea6
https://pubmed.ncbi.nlm.nih.gov/11405119
https://pubmed.ncbi.nlm.nih.gov/11405119